LinkedIn



CDC Health Advisory – Potential Contaminated IV Bags

June 2010

CDC Health Advisory – Potential Contaminated Metronidazole, Ondansetron, and Ciprofloxacin IV Bags

The FDA is alerting healthcare professionals not to use certain IV bags of metronidazole, ondansetron, and ciprofloxacin because of potential contamination. FDA has received reports of floating matter in IV bags manufactured by Claris Lifesciences Limited, in Ahmedabad, India. Microbiological analysis identified matter in one of the bags as a Cladosporium mold, which can cause infections in susceptible patients, such as those who are immunocompromised. Affected products manufactured by Claris Lifesciences Limited are sold under the following labels: Claris, Sagent Pharmaceuticals, Pfizer, West-Ward Pharmaceuticals.

To read the CDC Health Advisory, click here.